DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

IOL Chemicals and Pharmaceuticals Limited — Capacity addition (Sub-para 3-Para B)

NSE 1 hr ago·9 Sept 2026, 12:36 pm

IOL Chem AND Pharma

IOL Chemicals and Pharmaceuticals Limited has informed stock exchanges about a capacity addition initiative. This move involves expanding the company's production capabilities, likely to meet rising demand for its pharmaceutical and specialty chemical products.

For investors, this development signals the company's intent to scale up operations and strengthen its market position. Increased capacity can enhance revenue potential and operational efficiency, provided the expansion is executed effectively.

Investors should monitor the company's progress on this project, including timelines and cost management. Successful execution could boost long-term growth, while delays or cost overruns might impact profitability.